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Introduction
There are many infectious agents of clinical importance to 
cats and some have the potential for zoonotic significance 
to people. Stray cats often have high prevalence rates for 
most infectious agents that are associated with direct 
contact with other cats, including feline leukaemia virus 
(FeLV), feline immunodeficiency virus (FIV), the haemo-
plasmas, feline herpesvirus-1 (FHV-1), feline calicivirus 
(FCV), Mycoplasma species and Chlamydia felis. In addi-
tion, agents vectored by fleas (Bartonella species, the hae-
moplasmas) or ticks (Anaplasma phagocytophilum, Borrelia 
burgdorferi;) can also be very common in stray cats because 
parasite control products are usually not used in these cats.
In-clinic tests are available for detection of FeLV anti-
gens and FIV antibodies in serum. Recently, it was shown 
that an in-clinic assay designed for detection of antibod-
ies against A phagocytophilum, B burgdorferi, Ehrlichia 
canis and Dirofilaria immitis antigens in canine sera can be 
used with feline sera to detect A phagocytophilum and 
B burgdorferi antibodies.1 Molecular assays for amplifica-
tion of the RNA or DNA of multiple bloodborne infec-
tious agents are now widely available. While several 
studies have evaluated prevalence rates for vector-borne 
agents in cats in Spain, no study has combined the use of 
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molecular assays with the commercially available kit 
that can detect A phagocytophilum and B burgdorferi 
antibodies.2–8
The respiratory disease-causing agents FHV-1, FCV, 
Mycoplasma species, C felis and Bordetella bronchiseptica 
are generally common in cats housed in shelters, but, to 
our knowledge, no study has evaluated prevalence rates 
for these agents in cats in Spain.9–12 Additionally, mini-
mal studies exist that have genotyped respiratory 
Mycoplasma species from cats with and without clinical 
signs of disease, to evaluate for the presence of novel 
Mycoplasma species.13 Thus, the objectives of this part of 
the study were to use samples from cats housed in shel-
ters in Catalonia to determine the prevalence of selected 
vector-borne agents using molecular assays, to deter-
mine the B burgdorferi and A phagocytophilum antibody 
prevalence rates using a commercially available assay, to 
determine the prevalence of selected respiratory disease 
agents using molecular assays, and to genetically charac-
terise respiratory Mycoplasma species.
Materials and methods
Case selection
All cats were housed at local animal shelters in Barcelona 
(CAAC Barcelona, CAAC Mataró and CAAD Argentona) 
or had been admitted to a clinic (Bitxos, Hospitalet) out-
side Barcelona from different shelters or colonies, and 
permission to collect the samples was granted to each 
attending veterinarian. Performance of the study was 
approved by the Clinical Review Board of the Department 
of Clinical Sciences, Colorado State University. Cats 
were chosen solely on whether samples could be col-
lected (September–November 2012) without causing 
undue stress.
Clinical evaluation
Prior history was not available for the cats. For all cats, 
age was estimated by a veterinarian and stratified into 
kittens up to 16 weeks of age or adults. To our knowl-
edge, all the cats had outdoor access and had previous 
contact with other cats. Vaccines containing FHV-1, FCV 
and feline panleukopenia were administered to each of 
the cats at the shelters at the time of admission but not 
repeated regularly. Owing to the feral nature of most 
cats, a complete clinical evaluation was not possible, but 
cats were classified as healthy or unhealthy depending 
on the clinical history when available and presence of 
evident clinical signs.
Sample collection
Blood (1.5 ml) was collected from the jugular or cephalic 
vein and 0.5 ml placed into EDTA and 1 ml allowed to 
clot for serum separation. Oral or nasal swabs were col-
lected by inserting the tip of a sterile dry cotton urethral 
swab just inside the nares or between the cheek and 
gum, and gently rotated. All samples were stored at 
–80°C on the day of collection at the Autonomous 
University of Barcelona (Spain) until being shipped on 
ice packs to the Colorado State University (USA) and 
then stored at 4°C until assayed.
Serological assays
The 116 sera were tested for FeLV antigen and antibodies 
against FIV using a commercially available kit (SNAP 
Combo FeLV/FIV test; IDEXX) and for antibodies 
against A phagocytophilum, B burgdorferi, E canis and 
D immitis antigens using a different commercially 
available kit (SNAP 4Dx; IDEXX). IgG antibodies 
against Bartonella species were detected by ELISA 
using Bartonella henselae as the antigen source.14
Molecular assays
Positive and negative controls were assessed with all 
PCR assays using the previously published assays and 
standard operating procedures (Center for Companion 
Animal Studies, Colorado State University, Fort Collins, 
CO, USA). Total DNA was extracted from 200 µl of the 
116 blood samples in EDTA and assayed using PCR 
assays that amplify the DNA of Anaplasma species, 
Bartonella species, Ehrlichia species, haemoplasmas and 
Rickettsia species with genetic sequencing used to con-
firm the results.15–18 Total DNA and RNA were extracted 
from the 116 nasal or oral swab samples, and conven-
tional PCR assays that amplify the RNA of FCV, and the 
DNA of FHV-1, C felis and Mycoplasma species were per-
formed on each extract.19–23 Mycoplasma species-positive 
samples were sequenced to determine the species and 
only cases confirmed by sequencing were considered 
positive.13
Statistical analysis
As detailed information was not available for most cats 
and case selection was based on convenience sampling, 
the majority of the results are presented descriptively. 
Fisher’s exact test was used to compare the percentage 
of positive results between groups for some parameters, 
with significance defined as P <0.05.
Results
Bloodborne agents
There were 12 kittens aged between 5 and 16 weeks of 
age; the other 104 animals were estimated to be adult cats. 
Of the 116 cats, 63 (54.3%) had evidence of infection by 
Bartonella species, FeLV, FIV or a haemoplasma (Table 1). 
One healthy 3-month-old kitten was positive for B burg-
dorferi antibodies in serum. Anaplasma species, Ehrlichia 
species or Rickettsia species DNA was not amplified 
from these cats.
Overall, 51 cats (44%) had evidence of exposure to or 
infection by Bartonella species; B henselae and Bartonella 
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clarridgeaie were both detected individually and one cat 
had dual infection. Evidence of a Bartonella species expo-
sure or infection was more common in adults (48/104 
cats; 46.2%) than kittens (3/12 kittens; 25.0%), but the 
difference was not significant. Nine cats were Bartonella 
species PCR-positive but IgG negative. The majority of 
the cats with evidence of infection or exposure to 
Bartonella species were apparently healthy. DNA of 
‘Candidatus Mycoplasma haemominutum’ (eight cats) 
or Mycoplasma hemofelis (one cat) was amplified from 
the blood of 7.8% of cats; five cats had concurrent evi-
dence of infection or exposure to a species of Bartonella, 
but dual infections with both haemoplasmas were 
not detected. None of the haemoplasma cats had physi-
cal examination evidence of haemolytic anaemia. 
Haemoplasma DNA was not amplified from the blood 
of any kitten.
FeLV antigen was detected in the serum of seven cats 
(6.0%) (Table 1); six cats were positive for FeLV alone. 
FeLV antigen was detected in a higher percentage of kit-
tens (2/12; 16.7%) than adults (5/104; 4.8%), but the dif-
ference was not significant. Of the cats that were positive 
for FeLV alone, five were healthy and one had respiratory 
distress. Three cats (2.6%) were positive for FIV antibod-
ies and all were clinically ill. One cat positive for FIV anti-
bodies, FeLV antigen and ‘Candidatus M haemominutum’ 
DNA had gingivitis. One cat with FIV antibodies alone 
had haemolytic anaemia. The third FIV antibody-positive 
cat had gingivitis, Bartonella species IgG, and DNA of 
B clarridgeiae and ‘Candidatus M haemominutum’.
Upper respiratory disease agents
None of the 12 kittens sampled in this study had clinical 
signs of upper respiratory disease and all the kittens 
were negative for the selected agents. Eighteen of the 116 
cats (15.5%) were positive for FCV RNA (six cats), 
Mycoplasma species DNA (six cats), FHV-1 DNA (three 
cats) or C felis DNA (three cats). Of the 116 cats, 18 (15.5%) 
had clinical signs of upper respiratory infections (12.9%). 
Five cats had clinical signs of rhinitis alone, five cats had 
gingivitis alone, four cats had conjunctivitis alone, two 
cats had rhinitis and conjunctivitis, and two cats had res-
piratory distress. However, of the 18 cats with clinical 
signs of upper respiratory infections, only five cats were 
positive for any of the targeted infectious agents.
Of the Mycoplasma species, genetic sequencing 
showed three to be Mycoplasma arginini, two to be 
Mycoplasma gateae and one to be Mycoplasma feliminutum. 
One cat had FCV RNA, FHV-1 DNA and respiratory dis-
tress. One other FCV RNA-positive cat had conjunctivi-
tis and the other four cats had no signs of upper 
respiratory infection, including a cat that was positive 
for FCV RNA and M arginini DNA. The other two cats 
with FHV-1 DNA had conjunctivitis or had no signs of 
upper respiratory infection, respectively. Of the six 
Mycoplasma species DNA-positive cats, five had no signs 
of upper respiratory infection and one cat with M argin-
ini DNA had signs of conjunctivitis and rhinitis. Of the 
C felis DNA-positive cats, two had conjunctivitis and one 
had no signs of upper respiratory infection. None of the 
cats with gingivitis were positive for FCV RNA (Table 2).
Discussion
Overall, 54.3% of the 116 cats studied had evidence of 
exposure to a bloodborne agent. Consistent use of flea 
and tick preventives in the recent past in the cats 
described here was considered unlikely, which probably 
explains the Bartonella species prevalence rate of 44%, as 
many Bartonella species are transmitted by fleas. Both 
B henselae and B clarridgeaie are human pathogens and 
can be associated with illness in cats, and so the results 
suggest that flea control is indicated for cats in the region. 
The results of this study are similar to others in Spain 
that have shown Bartonella species seroprevalence rates 
of 23.8% (Madrid), 29.6% (Catalonia) and 71.4% 
(Catalonia and Mallorca Island).4,8,24 Other studies from 
Spain have documented B henselae and B clarridgeiae 
DNA in the blood of cats; however, the prevalence of 
22.4% reported here is much higher than other studies 
that ranged from 0.3–17%.4,5,8 The differences between 
studies likely relate to the source of the cats, with higher 
risk being associated with shelter cats because of flea 
exposure. Alternatively, the assays used were different 
among the studies, which could also explain the 
differences.
The haemoplasma prevalence rates in this study 
(7.8%) were similar to another in Catalonia, which 
reported DNA from all three major species in the blood 
of cats; the prevalence rates were 3.7% for M haemofelis, 
9.9% for ‘Candidatus M haemominutum’ and 0.5% 
for ‘Candidatus Mycoplasma turicensis’.7 In another 
Table 1 Prevalence of selected bloodborne agents in 116 
shelter cats from the Barcelona area
Result Positive
Any test positive 63 (54.3)
Any Bartonella positive (IgG or PCR) 51 (44.0)
 Bartonella IgG 41 (35.3)
 Bartonella PCR 26 (22.4)
  B henselae 17 (14.7)
  B clarridgeaie 10 (8.6)
Any haemoplasma  9 (7.8)
 ‘Candidatus Mycoplasma hemominutum’  8 (6.9)
 Mycoplasma hemofelis  1 (0.9)
FeLV  7 (6.0)
FIV  3 (2.6)
Data are n (%)
FeLV = feline leukaemia virus; FIV = feline immunodeficiency virus
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previous study of domestic cats in different Spanish 
provinces, haemoplasma DNA was amplified from the 
blood of 30% of the cats tested.4 Both studies were on 
domestic cats. No data are available for stray animals. 
Haemoplasmas have several routes of transmission, 
including vectors and direct contact; thus, stray cats may 
be at a greater risk of exposure to the infections.25
In this study, antibodies against E canis or Anaplasma 
species were not detected in the commercially available 
kit, and DNA of Anaplasma species, Ehrlichia species, 
Neorickettsia species or Rickettsia species were not ampli-
fied. The PCR assays have been validated for use with 
cat blood and so the negative results likely indicate low 
levels of exposure to these cats and are similar to other 
PCR-based studies in Spain, which also failed to amplify 
DNA of these genera from cat blood.4,5 In contrast, anti-
bodies against Rickettsia conori were detected in 44% of 
cats tested in Catalonia and Mallorca island,6 1–2.4% of 
cats tested had antibodies against Neorickettsia risticii,2,8 
and, in separate studies, antibodies against E canis have 
been detected in between 3.8% and 17.9% of cats.2–4,6,8 
The commercial antibody test kit used has been shown 
to detect A phagocytophilum antibodies in the serum of 
cats, but has not been validated to detect Ehrlichia spe-
cies antibodies in serum.1 Thus, Ehrlichia species anti-
body results of this study cannot be directly compared 
with the previous studies. However, as Ehrlichia species 
are known to induce clinical disease in cats, the previous 
seroprevalence studies suggest these agents and R conori 
should continue to be assessed as the cause of clinical 
illness in cats in Spain.
In the present study, one kitten was positive for B burg-
dorferi. There are no previous data about this infection in 
cats in Catalonia, which has never been considered an 
area at risk for Lyme disease. However, B burgorferi was 
found to have a low prevalence in dogs in central Spain 
and in people in northeast Spain.26,27 The commercial kit 
utilised here is known to detect B burgdorferi antibodies in 
cats,1 and so the result is likely a true positive. However, 
the kitten was young and so the positive test likely reflects 
maternal antibodies from the queen.
The prevalence rates for FeLV and FIV (6.0% and 
2.6%, respectively) were slightly lower than reported in 
a previous study in Catalonia and Mallorca island, where 
the prevalence rates were 8.5% for FeLV and 7.4% for 
FIV.4 One cat positive for FeLV was presented to the 
clinic in respiratory distress, but unfortunately no diag-
nostic tests were carried out to confirm or rule out a pos-
sible mediastinal lymphoma or other disease potentially 
related to FeLV. A few cats that presented with gingivitis 
had multiple infections: a FeLV-positive cat was also 
positive for FIV antibodies and ‘Candidatus M haemom-
inutum’ DNA. Another, which was positive for FIV, was 
also positive for Bartonella species IgG, and DNA of 
B clarridgeiae and ‘Candidatus M haemominutum’. Multiple 
infections are common in cats affected by FIV and most 
clinical signs are a consequence of secondary diseases.
The molecular assays used to amplify nucleic acids of 
FCV, FHV-1, C felis and Mycoplasma species were positive 
in 18/116 cats (15.5%) and each agent was amplified 
from more than one cat. To our knowledge, this is the 
first time that these agents have been documented in 
shelter cats in Spain. The prevalence rates compared 
with shelter studies in the USA are low.11 Similar to other 
studies, positive test results did not always correlate to 
the presence of clinical signs of disease. This is likely 
related, in part, to the use of modified live FHV-1- and 
FCV-containing vaccines: the persistence of these strains 
may explain how it was possible to obtain positive 
results for PCR assays on samples obtained from appar-
ently healthy cats.11 In addition, FHV-1, FCV, C felis and 
Mycoplasma species can also be carried by healthy cats. 
The pathogenicity of Mycoplasma species has been ques-
tioned in previous studies because it is frequently 
detected in samples obtained from clinically normal 
cats.28 It has been suggested that Mycoplasma species 
is pathogenic only when it is associated with other 
organisms.
Table 2 Prevalence of selected respiratory pathogens in 116 shelter cats from the Barcelona area
Result Positive* Cats with URTD signs (n) Cats with URTD signs over the number  
of positive to the test
Any test positive 18 (15.5) 5 27.8
FCV RNA  6 (5.2) 2 33.3
FHV-1 DNA  3 (2.6) 2 66.7
Chlamydia felis DNA  3 (2.6) 2 66.7
Mycoplasma species DNA  9 (7.8) 1 11.1
 M arginini  3 (2.6) 1 33.3
 M gateae  2 (1.7) 0 0
 M feliminutum  1 (0.9) 0 0
*Data are n (%)
URTD = upper respiratory tract disease; FCV = feline calicivirus; FHV-1 = feline herpesvirus-1
Ravicini et al 5
In this study two cats had positive results for both 
Mycoplasma species and FCV, but only one of them had 
conjunctivitis. A study carried out in Germany in 2010 
found a much higher prevalence of mycoplasmas in cats 
with conjunctivitis; 20/41 cats (48.8%) were positive.13 
However, in the present study the previous history of 
these cats was mostly unknown, so it is possible that some 
of these animals had episodes of conjunctivitis or rhinitis 
as kittens that were not observed at the shelters; therefore, 
subclinical carriage of organisms such as FHV-1 and FCV 
is another possible explanation.
There were many cats in the study with conjunctivitis 
and/or rhinitis from which DNA of an infectious agent 
was not amplified. These cats may have had another 
unrecognised cause of upper respiratory tract disease, 
such as B bronchiseptica infection. Moreover, specific 
information on antimicrobial treatment of cats was not 
available. It is possible that some cats in the present 
study were being treated with antimicrobials, which 
could have reduced the detection rates of C felis and 
Mycoplasma species in cats with conjunctivitis. However, 
this would be unlikely in the healthy cats. In future prev-
alence studies, it should be verified that samples are col-
lected before administration of antimicrobial treatments. 
It is also possible that the PCR assay results were falsely 
negative because of shipping. The samples were shipped 
from Spain to Colorado with ice packs, but arrived to the 
laboratory with melted ice and at ambient temperature. 
However, in another study results of FHV-1 DNA PCR 
assays did not differ for identical samples sent overnight 
on ice or mailed at ambient daytime temperatures dur-
ing a period of several days, indicating that shipping 
temperature should not be a major limiting factor in 
DNA assays, but it may be regarding FCV RNA.29 
Another explanation for the low rate of positives could 
be the sampling location, which included both nasal and 
gingival swabs. Previous studies have shown that oro-
pharyngeal samples could be ideal to obtain DNA for 
FHV-1 and RNA for FCV and respiratory pathogens.30,31
Conclusions
Clinical information from shelter cats like those reported 
herein is often limited. Thus, it is difficult to assess accu-
rately for disease associations in these studies. However, 
this work documents that shelter cats in Catalonia are 
exposed to many infectious agents with clinical and 
zoonotic significance. The Bartonella species prevalence 
rates suggest that flea control is indicated for cats in the 
region, as reported in previous studies in domestic cats.
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